Health Catalyst: Business Model, SWOT Analysis, and Competitors 2026

Health Catalyst, Inc. stands as a leading company in Healthcare. Generating $316.06 million in annual revenue (continuing to scale) and carrying a market capitalization of $136.51 million, the company has cemented its position as a foundational player in the global Health Information Services landscape. Under the leadership of its leadership team, Health Catalyst, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines Health Catalyst, Inc.'s business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating Health Catalyst, Inc. as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define Health Catalyst, Inc.'s position in the Health Information Services market today.

What You Will Learn

1. How Health Catalyst, Inc. generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering Health Catalyst, Inc.'s competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who Health Catalyst, Inc.'s main competitors are and how the company compares on key financial metrics
4. Health Catalyst, Inc.'s key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. Health Catalyst, Inc.'s strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $316.06 million annual revenue (TTM)
• Market Cap: $136.51 million — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 47.5%, operating margin -10.0%, net margin -34.1%
• Free Cash Flow: $4.14 million
• Return on Equity: -31.3% — reflects current investment phase
• Employees: 1,500 worldwide

Who Owns Health Catalyst, Inc.?

Health Catalyst, Inc. is publicly traded on the NMS under the ticker symbol HCAT. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of Health Catalyst, Inc. are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

Health Catalyst, Inc. has approximately 0.07 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $1.93 per share as of early 2026.

Health Catalyst, Inc.'s Mission Statement

Health Catalyst, Inc.'s strategic mission is aligned with its core business activities in the Health Information Services sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — Health Catalyst, Inc.'s most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For Health Catalyst, Inc., the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, Health Catalyst, Inc.'s strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does Health Catalyst, Inc. Make Money?

As of 2026, Health Catalyst, Inc. generates $316.06 million in annual revenue, with a 47.5% gross margin and -10.0% operating margin. Market capitalization stands at $136.51 million. Here is how the company generates its revenue:

Health Catalyst takes data security seriously by implementing robust security measures and compliance protocols to protect sensitive healthcare data from cyber threats.

What trends are likely to influence Health Catalyst's future?

Key trends influencing Health Catalyst's future include the shift toward value-based care, advancements in AI and machine learning, the rise of telehealth, and evolving regulatory landscapes.

By exploring the multifaceted aspects of Health Catalyst Inc., this article provides a comprehensive understanding of the company's position in the healthcare technology sector as we move into 2024.

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review Health Catalyst, Inc.'s latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

Health Catalyst, Inc. Business Model Canvas

The Business Model Canvas framework provides a structured view of how Health Catalyst, Inc. creates, delivers, and captures value.

Key Partners: Health Catalyst, Inc.'s key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Health Information Services sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: Health Catalyst, Inc.'s most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: Health Catalyst, Inc.'s critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (1,500 employees), proprietary technology, and financial resources ($91.54M in cash).

Value Propositions: Health Catalyst, Inc. delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Health Information Services market.

Customer Relationships: Health Catalyst, Inc. maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: Health Catalyst, Inc. reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: Health Catalyst, Inc. serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: Health Catalyst, Inc.'s major costs include cost of goods sold (52.5% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 110.0% of revenue.

Revenue Streams: Health Catalyst, Inc. generates revenue through its core product and service offerings.

Health Catalyst, Inc. Competitors

Health Catalyst, Inc. competes against Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Pfizer (PFE), AbbVie (ABBV), Eli Lilly (LLY) and others in the Health Information Services segment of the Healthcare sector.

Health Catalyst, Inc. SWOT Analysis

A SWOT analysis examines Health Catalyst, Inc.'s internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Strong Margins: Health Catalyst, Inc.'s gross margin of 47.5% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of -10.0% demonstrates disciplined cost management even at scale.

Weaknesses

• Leverage Risk: Health Catalyst, Inc.'s debt-to-equity ratio of 51.9 indicates meaningful financial leverage. Total debt stands at $172.12M against $91.54M in cash and equivalents.

Opportunities

• Total Addressable Market: Health Catalyst, Inc. operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Health Catalyst, Inc.'s products and services.
• Strategic Acquisitions: With $91.54M in cash and strong free cash flow generation, Health Catalyst, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Health Catalyst, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Health Catalyst, Inc.'s business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

Health Catalyst, Inc. enters 2026 as a leading company in Healthcare, backed by $316.06 million in annual revenue and a -34.1% net profit margin. The company's 47.5% gross margins and $4.14 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in Health Catalyst, Inc.'s core markets.

For investors and analysts, Health Catalyst, Inc. represents an important company to understand within the Healthcare sector. Key metrics to track include revenue growth, margin trends, and competitive positioning updates.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – Health Catalyst, SEC EDGAR – Health Catalyst Filings, and Health Catalyst's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. What is Health Catalyst Inc.?

Health Catalyst, Inc. generated $316.06 million in annual revenue with a -34.1% net profit margin as of the latest reporting period. The company operates in the Health Information Services sector. For the most current information, consult Health Catalyst, Inc.'s investor relations page.

2. What is the business model of Health Catalyst?

Health Catalyst, Inc. generates $316.06 million in annual revenue (TTM) with a 47.5% gross margin. The company's revenue model is described in detail in the business model section above.

3. Who are the main competitors of Health Catalyst?

Health Catalyst, Inc. competes in the Health Information Services segment of the Healthcare sector. The competitor comparison table in this article outlines key peers by market cap, revenue, and margins. Competitive dynamics in Health Information Services center on product differentiation, pricing strategy, and distribution scale.

4. What are some strengths of Health Catalyst?

Health Catalyst, Inc.'s core strengths include: Health Catalyst, Inc.'s gross margin of 47.5% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of -10.0% demonstrate These advantages contribute to the company's durable competitive position in the Health Information Services sector.

5. What are the potential opportunities for Health Catalyst?

Health Catalyst, Inc.'s key growth opportunities include: Health Catalyst, Inc. operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Health With $91.54M in cash and strong free cash flow generation, Health Catalyst, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

6. How does Health Catalyst address data security concerns?

Health Catalyst, Inc. generates $316.06 million in annual revenue (TTM) with a 47.5% gross margin. The company's revenue model is described in detail in the business model section above.

7. What trends are likely to influence Health Catalyst's future?

Health Catalyst, Inc.'s key growth opportunities include: Health Catalyst, Inc. operates in the Health Information Services segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Health With $91.54M in cash and strong free cash flow generation, Health Catalyst, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.